4//SEC Filing
Robinson James A. Jr. 4
Accession 0000899243-21-014110
CIK 0001740547other
Filed
Mar 30, 8:00 PM ET
Accepted
Mar 31, 12:30 PM ET
Size
13.2 KB
Accession
0000899243-21-014110
Insider Transaction Report
Form 4
Robinson James A. Jr.
Director
Transactions
- Disposition to Issuer
Stock Appreciation Right (Right to Buy)
2021-03-29−845,732→ 0 totalExercise: $9.16Exp: 2030-03-22→ Common Shares (845,732 underlying) - Disposition to Issuer
Common Shares
2021-03-29−8,385→ 0 total - Disposition to Issuer
Stock Option (Right to Buy)
2021-03-29−50,000→ 0 totalExercise: $12.41Exp: 2029-03-01→ Common Shares (50,000 underlying) - Disposition to Issuer
Stock Option (Right to Buy)
2021-03-29−25,000→ 0 totalExercise: $8.78Exp: 2029-07-09→ Common Shares (25,000 underlying)
Footnotes (3)
- [F1]Upon the consummation of the Merger, each outstanding common share of the Issuer ("Common Share") was cancelled and converted into the right to receive $16.25 per share in cash, without interest and less any applicable withholding for taxes, as described in the Merger Agreement.
- [F2]Upon consummation of the Merger, each option to purchase Common Shares that was outstanding and unexercised immediately prior to the effective time of the Merger, whether vested or unvested, and that had an exercise price per Common Share that is less than $16.25 was cancelled and automatically converted into the right to receive a cash amount for each Common Share that is subject to such option that is equal to the difference between $16.25 and the per share exercise price of such option, without interest and less any applicable withholding for taxes, as described in the Merger Agreement.
- [F3]Upon consummation of the Merger, each right to receive an appreciation on Common Shares that was outstanding and unexercised immediately prior to the effective time of the Merger, whether vested or unvested, and that had a strike price per Common Share that is less than $16.25 was canceled and automatically converted into the right to receive a cash amount for each Common Share that is subject to such appreciation right that is equal to the difference between $16.25 and the strike price per Common Share of such appreciation right, without interest and less any applicable withholding for taxes, as described in the Merger Agreement.
Documents
Issuer
Urovant Sciences Ltd.
CIK 0001740547
Entity typeother
Related Parties
1- filerCIK 0001734295
Filing Metadata
- Form type
- 4
- Filed
- Mar 30, 8:00 PM ET
- Accepted
- Mar 31, 12:30 PM ET
- Size
- 13.2 KB